试点三年成效显著 经营者集中审查转为正式委托

Core Insights - The State Administration for Market Regulation (SAMR) has transitioned the pilot program for antitrust reviews into a formal program after three years of successful trials in five provinces and cities [1][2] Group 1: Pilot Program Overview - The pilot program, running from August 1, 2022, to July 31, 2025, aimed to enhance the efficiency of antitrust reviews in Beijing, Shanghai, Guangdong, Chongqing, and Shaanxi [1] - During the pilot, the SAMR optimized the review process for simple cases, implementing a "double twenty" internal requirement, which stipulates that from submission to acceptance should not exceed 20 days, and from acceptance to conclusion should also not exceed 20 days [1] - The number of cases reviewed during the pilot totaled 1,288, with 1,162 concluded, achieving average acceptance and conclusion times of 16.9 days and 17.4 days respectively, significantly improving investment and merger efficiency [1] Group 2: Regional Contributions - The Shanghai Municipal Market Regulation Bureau, responsible for reviewing cases in Shanghai, Jiangsu, Zhejiang, Anhui, Fujian, Jiangxi, and Shandong, concluded 433 cases, accounting for 40% of the total pilot cases [2] - The Chongqing Municipal Market Regulation Bureau handled cases in eight provinces and regions, concluding 207 cases, focusing on enhancing work support, review quality, and collaborative efforts [2] Group 3: Regulatory Actions - The SAMR has recently prohibited the acquisition of Shandong Beida High-Tech Huatai Pharmaceutical Co., Ltd. by Wuhan Yitong Medical Co., Ltd., and imposed restrictive conditions on several other acquisitions, indicating a proactive stance on maintaining competitive market conditions [2][3] - The SAMR aims to continue enhancing the classification and tiered review of operator concentrations, focusing resources on cases that may restrict competition [3]